Dr. Frances Shepherd CV - (NCRI) is

cancer. Presented at the IASLC 14 th World Conference on Lung Cancer, Amsterdam June
2011. J Thorac Oncol 2011; 6: S621-22
86. Goss GD, Addison CL, Ding K, Zhao H, Le Maitre A, Laurie S, Shepherd FA, Bradbury
PA, Seymour L. Circulation plasma angiogenic factors and soluble receptors in NCIC
CTG BR.24. Presented at the IASLC 14 th World Conference on Lung Cancer,
Amsterdam June 2011. J Thorac Oncol 2011; 6: S673.
87. Leighl N, Salvarrey A, Kassam F, Le L, Shepherd FA, Feld R, Tang F, Hollen P, Gralla
RJ. Preliminary report of a randomized trial computer-assisted quality of life assessment
in advanced NSCLC patients. Presented at the IASLC 14 th World Conference on Lung
Cancer, Amsterdam June 2011. J Thorac Oncol 2011; 6: S1120-21.
88. Laurie SA, Goss GD, Shepherd FA, Reaume N, Nicholas G, Philip L, Wang L, Oza A,
Hirsch V, Wright J, Leighl N. An inhibitor of SRC kinases, in platinum-preterated
advanced non-small cell lung cancer (NSCLC): a trial of the PMH Phase II Consortium.
Presented at the IASLC 14 th World Conference on Lung Cancer, Amsterdam June 2011.
J Thorac Oncol 2011; 6: S1262.
89. Guiliani ME, Lindsay PE, Sun A, Bezjak A, Le L, Brade A, Cho J, Leighl NB, Shepherd
FA, Hope A. Correlation of dosimetric factors in the development of esophagitis and
radiation pneumonitis in patients with limited stage non-small cell lung carcinoma.
Presented at the IASLC 14 th World Conference on Lung Cancer, Amsterdam June 2011.
J Thorac Oncol 2011; 6: S1348.
90. Brade AM, Bezjak A, MAcrae R, Laurie SA, Burkes R, Chu Q, Wang L, Goffin JR,
Grishma S, Capobianco S, Iscoe N, Shepherd FA. A phase II study evaluation
concurrent pemetrexed/cisplatin/radiation (RT) for unresectable stage III A/B non-small
cell lung cancer (NSCLC). Presented at the IASLC 14 th World Conference on Lung
Cancer, Amsterdam June 2011. J Thorac Oncol 2011; 6: S1543-44.
24